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Before stapling devices, arteriovenous fis-
tulas would be sutured and resected. When
staplers became available, I was able to
isolate and resect the arteriovenous fistulas
with good results. Arteriovenous fistulas
the size of an apple or larger (7-8 cm) may
be excised without the removal of normally
functioning pulmonary tissue with this
technique.
The lesions, which may be multiple and
bilateral, are relatively easy to delineate
and dissect in preparation for removal. I
have not used anticoagulation and have not
had any difficulty with embolism. Most
such patient concerns have been suspected
as a result of routine chest radiography and
follow-up with computed tomography. The
results of magnetic resonance imaging, as
compared with contrast angiography, will
be interesting in the future. Currently I first
consider embolization, especially when the
lesions are small, multiple, and bilateral. If
the lesion is large or the catheter technique
is not desired, I proceed to resection. I
understand that in most cases embolic ther-
apy is preferred at this time; however, there
is still a place for primary resection of the
large or coincidentally found lesion. Such a
resection may be performed with a pulmo-
nary-sparing technique.
Raymond A. Dieter, Jr, MD
The Center for Surgery
General Surgery
475 Diehl Rd
Naperville, IL 60563
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Aortic valve regurgitation associated
with a fibrous band between the
leaflet and the aortic wall
To the Editor:
We read with great interest the article of
Nakajima and associates1 in the October
2002 issue of the Journal, “Aortic Regur-
gitation Caused by Rupture of a Well-Bal-
anced Fibrous Strand Suspending a Degen-
erative Tricuspid Aortic Valve.” They
showed a unique case with aortic valve
regurgitation. The well-balanced aortic val-
vular apparatus shown in their case report
has not been reported previously. They in-
ferred the rupture of one the six fibrous
strands between the three aortic leaflets and
the ascending aorta as a cause of aortic
valve incompetence, because the other two
leaflets suspended by intact strands were
expected to function well.
We have seen two cases of strands in
bicuspid aortic valves. The patients were 25-
and 45-year-old men. Preoperative echocar-
diographic study of both patients showed the
presence of strands, and the related leaflet
was prolapsed toward the left ventricle in the
second case. Unfortunately, we could not get
a definite preoperative diagnosis of the pres-
ence of the strand in our first case, although
we recognized it retrospectively. However,
we were able to point out the presence in the
second case before operating (Figure 1), and
operative findings endorsed the preoperative
study. The strands were not ruptured in both
cases. The proximal ends of the strands were
situated on the conjoined portion of the fused
leaflets, and the distal ends were around the
sinotubular junction of the ascending aorta.
The left and right leaflets were fused in both
cases. The patients underwent aortic valve
replacement. The resected leaflets showed a
mucinous degeneration without inflamma-
tion. Our operative and pathologic findings
were similar to those in previous reports of
such strands.
Embryologically, the aortic valve is
formed through truncus ridge elaboration
in the truncus arteriosus. We therefore hy-
pothesize that these strands may be embry-
ogenic remnants during the semilunar cusp
formation process of the aortic valve.2 Na-
kajima and associates1 mentioned that rup-
ture of a well-balanced fibrous strand sus-
pending a degenerative tricuspid aortic
valve was the cause of aortic regurgitation.
They confirmed that the well-balanced fi-
brous strands existed between the intact
leaflets and the ascending, suspending two
leaflets with a good coaptation. They lik-
Figure 1. Preoperative echocardiography. A, Long-axis view of left ventricular outflow shows strand between
leaflet and ascending aorta (arrows). B, Short-axis view of ascending aorta also shows strand as small
high-echoic shadow in ascending aorta (wedges).
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ened the strand development to a similar
embryologic process in bicuspid aortic
valve cases. The causes of such a strand
formation may be more complicated than
those of previously reported cases associ-
ated with bicuspid aortic valves. Ours and
other cases had a strand between the fused
valve and the aortic wall, whereas their
case had three pairs of strands in three
leaflets. It is not easy to explain these for-
mations as embryogenic remnants. As Na-
kajima and associates1 mentioned, how-
ever, their case may indicate another aspect
for aortic valve surgery. Suspending a pro-
lapsed aortic valve between its leaflets and
the aortic sinotubular junction with a paired
artificial strands may be an option for aortic
valve repair. Additional case reports and
hemodynamic and physiologic confirma-
tion will be necessary.
Yoshio Misawa, MD
Shin-ichi Oki, MD
Katsuo Fuse, MD
Division of Cardiovascular Surgery
Jichi Medical School
3311-1 Yakushiji, Minami-kawachi
Tochigi, 329-0498, Japan
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Do macrophages and monocytes
impede regeneration of transplanted
cardiomyocytes?
To the Editor:
I read with great interest the article of To-
mita and colleagues1 entitled “Improved
Heart Function With Myogenesis and An-
giogenesis After Autologous Porcine Bone
Marrow Stromal Cell Transplantation” in a
recent issue of the Journal. My research
team has had similar results in both our
animal and clinical experiences. In our an-
imal experience, however, a lack of fibrous
tissue in the infarcted region after cell
patch cardiomyoplasty and omentopexy
procedures prompts me to believe that
macrophages and monocytes may contrib-
ute importantly to the disappearance of fi-
brotic tissue, thus preventing the regenera-
tion of the myocytes from progressing. I
therefore wonder whether similar findings
were seen in Tomita and colleagues1 cell
transplant experiments. I would greatly ap-
preciate a response to this inquiry.
S. Taheri, MD
Suite C
9095 Main St
Clarence, NY 14031
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Problems in assessment of serum
carcinoembryonic antigen levels in
cancers
To the Editor:
In a recent issue, Saito and colleagues1
reported on a multicenter retrospective re-
view of surgery for pulmonary metastasis
from colorectal cancer. They concluded
that the status of the hilar or mediastinal
lymph nodes and prethoracotomy carcino-
embryonic antigen (CEA) level were sig-
nificant independent prognostic factors. I
believe these findings are useful in the fol-
low-up of patients who have undergone
resection of pulmonary metastasis of colo-
rectal cancer. Prethoracotomy serum CEA
levels are also a prognostic indicator in
non–small cell lung cancer when the cutoff
level is defined as 6. 9 ng/dL on the basis of
the 95% specificity level for benign lung
disease.2
There are many kits to measure serum
CEA levels. The antibodies used by the
various methods vary. Thus there are some
cross-reactive normal antigens that are cal-
culated by some kits, and the maximum
normal serum level of CEA ranges from
2.5 ng/dL to 6.9 ng/dL.3 In the study that
Saito and colleagues1 conducted, 10.0
ng/dL was used as a cutoff level that influ-
enced the prognosis. This level is from 1.4
times to 4 times the upper limit of normal
for serum CEA level.
In a multicenter study, the variable for
serum CEA level should be considered nor-
mal or high according to a cutoff level
established by each individual institution.
Otherwise, the specification of a single
type of kit to measure serum CEA levels is
needed when a specific serum CEA level is
defined as the cutoff level. Either method, I
believe, will make serum CEA levels a
more significant prognostic indicator for
patients with lung cancer or patients with
pulmonary metastases from colorectal can-
cer.
Noriyoshi Sawabata, MD
Division of Surgery
Toneyama National Hospital
Osaka, Japan
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Reply to the Editor:
My coauthors and I appreciate the com-
ments of Sawabata concerning our article.
As he states, during the long term of our
retrospective study, several methods, such
as enzyme immunoassay and radioimmu-
noassay, were used to measure serum car-
cinoembryonic antigen (CEA) levels.
Many kits to measure serum CEA levels
are available in Japan, and results vary with
each assay. This leads to confusion among
physicians when evaluating serum values
detected by the different assay kits. One
does need to pay attention when evaluating
such archival data stored in medical
records.
In a multi-institutional study, ideally all
data from various institutions would be
measured by the same method with identi-
cal assay kits. However, it may be difficult
to measure serum CEA with the same assay
kit in each institution for various reasons,
including cost considerations and available
assay equipment. Moreover, the kits com-
monly used in Japan may be different from
ones used in the United States or Europe,
also making it difficult to compare the data
among them. It may be necessary to set up
an international committee to solve the is-
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